Thermosensitive Tri-Block Polymer Nanoparticle-Hydrogel Composites as Payloads of Natamycin for Antifungal Therapy Against Fusarium Solani

References

• Prajna NV, Srinivasan M, Lalitha P, et al. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmol. 2013;131:1088–1089. doi:10.1001/jamaophthalmol.2013.1612
   PubMed Web of Science ®Google Scholar
• Verma A, Sharma G, Jain A, et al. Systematic optimization of cationic surface engineered mucoadhesive vesicles employing Design of Experiment (DoE): a preclinical investigation. Int J Biol Macromol. 2019;133:1142–1155. doi:10.1016/j.ijbiomac.2019.04.118
   PubMed Web of Science ®Google Scholar
• Khames A, Khaleel MA, El-Badawy MF, El-Nezhawy AOH. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Int J Nanomedicine. 2019;14:2515–2531. doi:10.2147/IJN.S190502
   PubMed Web of Science ®Google Scholar
• Wang L, Sun S, Jing Y, Han L, Zhang H, Yue J. Spectrum of fungal keratitis in central China. Clin Exp Ophthalmol. 2009;37:763–771. doi:10.1111/j.1442-9071.2009.02155.x
   PubMed Web of Science ®Google Scholar
• He D, Hao J, Zhang B, et al. Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani. Invest Ophthalmol Vis Sci. 2011;52:2804–2808. doi:10.1167/iovs.10-5977
   PubMed Web of Science ®Google Scholar
• Xie L, Zhong W, Shi W, Sun S. Spectrum of fungal keratitis in North China. Ophthalmology. 2006;113:1943–1948. doi:10.1016/j.ophtha.2006.05.035
   PubMed Web of Science ®Google Scholar
• Lin Y, Zhang J, Han X, Hu J. A retrospective study of the spectrum of fungal keratitis in southeastern China. Ann Palliat Med. 2021;10(9):9480–9487. doi:10.21037/apm-21-1949
   PubMed Web of Science ®Google Scholar
• El-Emam GA, Girgis GNS, MMA E-S, El-Azeem Soliman OA, Abd El Gawad AEGH. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. Int J Nanomedicine. 2020;15:7825–7840. doi:10.2147/IJN.S268208
   PubMed Web of Science ®Google Scholar
• Huang J-F, Zhong J, Chen G-P, et al. A hydrogel-based hybrid theranostic contact lens for fungal keratitis. ACS Nano. 2016;10:6464–6473. doi:10.1021/acsnano.6b00601
   PubMed Web of Science ®Google Scholar
• Huang D, Chen Y-S, Rupenthal ID. Overcoming ocular drug delivery barriers through the use of physical forces. Adv Drug Deliv Rev. 2018;126:96–112. doi:10.1016/j.addr.2017.09.008
   PubMed Web of Science ®Google Scholar
• Lalu L, Tambe V, Pradhan D, et al. Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions. J Control Release. 2017;268:19–39. doi:10.1016/j.jconrel.2017.07.035
   PubMed Web of Science ®Google Scholar
• O’day DM, Head WS, Robinson RD, Clanton JA. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986;5:877–882. doi:10.3109/02713688609029240
   PubMed Web of Science ®Google Scholar
• Morsi N, Ghorab D, Refai H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016;506:57–67. doi:10.1016/j.ijpharm.2016.04.021
   PubMed Web of Science ®Google Scholar
• Kalavathy CM, Parmar P, Kaliamurthy J, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea. 2005;24(4):449–452. doi:10.1097/01.ico.0000151539.92865.3e
   PubMed Web of Science ®Google Scholar
• Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131:422–429. doi:10.1001/jamaophthalmol.2013.1497
   PubMed Web of Science ®Google Scholar
• Patil A, Majumdar S. Echinocandins in ocular therapeutics. J Ocul Pharmacol Ther. 2017;33:340–352. doi:10.1089/jop.2016.0186
   PubMed Web of Science ®Google Scholar
• Singh J, Chhabra G, Pathak K. Development of Acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study. Drug Dev Ind Pharm. 2014;40:1223–1232. doi:10.3109/03639045.2013.814061
   PubMed Web of Science ®Google Scholar
• Djekic L, Ibric S, Primorac M. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems. Int J Pharm. 2008;361:41–46. doi:10.1016/j.ijpharm.2008.05.002
   PubMed Web of Science ®Google Scholar
• Chhonker YS, Prasad YD, Chandasana H, et al. Amphotericin-B entrapped lecithin/chitosan nanoparticles for prolonged ocular application. Int J Biol Macromol. 2015;72:1451–1458. doi:10.1016/j.ijbiomac.2014.10.014
   PubMed Web of Science ®Google Scholar
• Younes NF, Abdel-Halim SA, Elassasy AI. Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm. 2018;553:386–397. doi:10.1016/j.ijpharm.2018.10.057
   PubMed Web of Science ®Google Scholar
• Tavakoli N, Taymouri S, Saeidi A, Akbari V. Thermosensitive hydrogel containing sertaconazole loaded nanostructured lipid carriers for potential treatment of fungal keratitis. Pharm Dev Technol. 2019;24:891–901. doi:10.1080/10837450.2019.1616755
   PubMed Web of Science ®Google Scholar
• Patil A, Lakhani P, Taskar P, et al. Formulation development, optimization, and in vitro-in vivo characterization of natamycin-loaded PEGylated nano-lipid carriers for ocular applications. J Pharm Sci. 2018;107(8):2160–2171. doi:10.1016/j.xphs.2018.04.014
   PubMed Web of Science ®Google Scholar
• Hosny KM, Rizg WY, Alkhalidi HM, et al. Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment. Drug Deliv. 2021;28:1836–1848. doi:10.1080/10717544.2021.1965675
   PubMed Web of Science ®Google Scholar
• Guo Y, Karimi F, Fu Q, Qiao G, Zhang H. Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution. Expert Opin Drug Deliv. 2020;17:407–421. doi:10.1080/17425247.2020.1719995
   PubMed Web of Science ®Google Scholar
• Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G, Dhawan S. PLGA: a unique polymer for drug delivery. Ther Deliv. 2015;6:41–58. doi:10.4155/tde.14.91
   PubMed Web of Science ®Google Scholar
• Mir M, Ahmed N, Ur Rehman A. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces. 2017;159:217–231. doi:10.1016/j.colsurfb.2017.07.038
   PubMed Web of Science ®Google Scholar
• Ganaha F, Kao EY, Wong H, et al. Stent-based controlled release of intravascular angiostatin to limit plaque progression and in-stent restenosis. J Vasc Interv Radiol. 2004;15(6):601–608. doi:10.1097/01.rvi.0000127888.70058.93
   PubMed Web of Science ®Google Scholar
• Agrahari V, Agrahari V. Advances and applications of block-copolymer-based nanoformulations. Drug Discov Today. 2018;23:1139–1151. doi:10.1016/j.drudis.2018.03.004
   PubMed Web of Science ®Google Scholar
• Russo E, Villa C. Poloxamer hydrogels for biomedical applications. Pharmaceutics. 2019;11:671. doi:10.3390/pharmaceutics11120671
   PubMed Web of Science ®Google Scholar
• Agrahari V, Agrahari V, Mitra AK. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Ther Deliv. 2016;7:257–278. doi:10.4155/tde-2015-0012
   PubMed Web of Science ®Google Scholar
• Qian Y, Wang F, Li R, Zhang Q, Xu Q. Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide. Drug Dev Ind Pharm. 2010;36(11):1340–1347. doi:10.3109/03639041003801893
   PubMed Web of Science ®Google Scholar
• Permana AD, Utami RN, Layadi P, et al. Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis. Int J Pharm. 2021;602:120623. doi:10.1016/j.ijpharm.2021.120623
   PubMed Web of Science ®Google Scholar
• Kong X, Xu W, Zhang C, Kong W. Chitosan temperature-sensitive gel loaded with drug microspheres has excellent effectiveness, biocompatibility and safety as an ophthalmic drug delivery system. Exp Ther Med. 2018;15(2):1442–1448. doi:10.3892/etm.2017.5586
   PubMed Web of Science ®Google Scholar
• Nafea EH, El-Massik MA, El-Khordagui LK, Marei MK, Khalafallah NM. Alendronate PLGA microspheres with high loading efficiency for dental applications. J Microencapsul. 2007;24:525–538. doi:10.1080/02652040701439807
   PubMed Web of Science ®Google Scholar
• Figueiredo M, Esenaliev R. PLGA nanoparticles for ultrasound-mediated gene delivery to solid tumors. J Drug Deliv. 2012;2012:767839. doi:10.1155/2012/767839
   PubMedGoogle Scholar
• Rafiei P, A. H. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–947. doi:10.2147/IJN.S121881
   PubMed Web of Science ®Google Scholar
• Lv J, Yang J, Hao X, Ren X, Feng Y, Zhang W. Biodegradable PEI modified complex micelles as gene carriers with tunable gene transfection efficiency for ECs. J Mater Chem B. 2016;4(5):997–1008. doi:10.1039/c5tb02310f
   PubMed Web of Science ®Google Scholar
• Wang J, Li S, Chen T, et al. Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application. J Mater Sci Mater Med. 2019;30:93. doi:10.1007/s10856-019-6294-y
   PubMed Web of Science ®Google Scholar
• Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci. 2003;44:210–216. doi:10.1167/iovs.02-0446
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrín M, Sáez V, et al. Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP). Biomaterials. 2007;28:1553–1564. doi:10.1016/j.biomaterials.2006.11.028
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RFV. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm. 2010;75(2):186–193. doi:10.1016/j.ejpb.2010.02.011
   PubMed Web of Science ®Google Scholar
• Kojarunchitt T, Baldursdottir S, Dong Y-D, Boyd BJ, Rades T, Hook S. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems. Eur J Pharm Biopharm. 2015;89:74–81. doi:10.1016/j.ejpb.2014.11.026
   PubMed Web of Science ®Google Scholar
• Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 2011;49:832–864. doi:10.1002/polb.22259
   PubMed Web of Science ®Google Scholar
• Arbade GK, Srivastava J, Tripathi V, Lenka N, Patro TU. Enhancement of hydrophilicity, biocompatibility and biodegradability of poly(ε-caprolactone) electrospun nanofiber scaffolds using poly(ethylene glycol) and poly(L-lactide-co-ε-caprolactone-co-glycolide) as additives for soft tissue engineering. J Biomater Sci. 2020;31(13):1648–1670. doi:10.1080/09205063.2020.1769799
   PubMed Web of Science ®Google Scholar